Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT04787991 ×

NCT04787991

This funder is selected. Its supporting articles are shown below.

NCT047879911

Articles mentioning NCT04787991

1 articles · page 1 of 1

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma

jitc · abstract · 2026-01-30 · 1 matching annotations

76.9%

NCT04787991 hydroxychloroquine gemcitabine nivolumab ipilimumab nab-paclitaxel hydroxychloroquine-related mPDAC cytotoxic therapy chemoimmunotherapy combinations+2 more

…unotherapy combinations in untreated mPDAC.Methods REVOLUTION ( NCT04787991) is an open-label, exploratory platform trial. Patients were as…